Mirati Therapeutics - Stock Price History | MRTX

Historical daily share price chart and data for Mirati Therapeutics since 2021 adjusted for splits. The latest closing stock price for Mirati Therapeutics as of September 24, 2021 is 166.36.
  • The all-time high Mirati Therapeutics stock closing price was 240.27 on December 10, 2020.
  • The Mirati Therapeutics 52-week high stock price is 249.42, which is 49.9% above the current share price.
  • The Mirati Therapeutics 52-week low stock price is 131.47, which is 21% below the current share price.
  • The average Mirati Therapeutics stock price for the last 52 weeks is 183.75.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Mirati Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 135.4310 116.2100 240.2700 69.7800 219.6400 70.45%
2019 84.2607 44.6500 128.8600 43.6500 128.8600 203.77%
2018 40.3518 18.6500 62.7000 17.2000 42.4200 132.44%
2017 7.6617 5.2000 19.0000 2.8000 18.2500 284.21%
2016 12.1726 29.0700 29.0700 4.5600 4.7500 -84.97%
2015 29.6934 19.2400 47.7000 19.2400 31.6000 70.63%
2014 18.8792 16.9800 24.8000 14.2000 18.5200 11.37%
2013 13.7241 7.0500 19.2000 7.0500 16.6300 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $8.891B $0.013B
Mirati Therapeutics, Inc. is a biopharmaceutical company. It engaged in the development of novel therapeutics for the treatment of cancer. Mirati Therapeutics, Inc., formerly known as MethylGene Inc., is based in Montreal, Canada.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71